Damicam generic name Gliclazide extended-release tablets, is able to take with Dagliflozin, the two drugs have different mechanisms of action, can be taken together to synergistically lower blood sugar. 1. Gliclazide extended-release tablets: used when diet therapy, exercise therapy and weight loss alone is insufficient to control blood glucose levels in adults with non-islet-dependent diabetes mellitus, allergic to gliclazide or one of the excipients, other sulfonylureas, sulfonamides are contraindicated, the common adverse effects of headache, extreme hunger, nausea, vomiting and so on. 2. Dagliflozin: It can be used as monotherapy to improve glycemic control in adult patients with type 2 diabetes mellitus. Hypotension, ketoacidosis, acute kidney injury and renal impairment are common adverse reactions, and is contraindicated in patients with a history of severe hypersensitivity to the product, and is contraindicated in patients with severe renal impairment, end-stage renal disease, or patients in need of dialysis. The use of medication must be carried out in accordance with the doctor’s instructions, and to read the instructions carefully.